Lifeward Ltd.(LFWD)Earnings, Financials & Key Ratios
LFWD•NASDAQ
$7.00
$11M mkt cap·Price updated May 6, 2026
AboutLifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.Show more
- Revenue$22M-14.1%
- EBITDA-$17M-5.4%
- Net Income-$20M+31.2%
- EPS (Diluted)-17.16+57.1%
- Gross Margin38.25%+19.5%
- EBITDA Margin-75.15%-22.7%
- Operating Margin-76.66%-0.6%
- Net Margin-90.38%+19.9%
- ROE-146.12%-65.0%
- ROIC-122.94%-38.8%
- Debt/Equity0.19+303.5%
- Interest Coverage-57.26+62.5%
LFWD Key Insights
Lifeward Ltd. (LFWD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 38.1%
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
LFWD Price & Volume
Lifeward Ltd. (LFWD) stock price & volume — 10-year historical chart
Loading chart...
LFWD Growth Metrics
Lifeward Ltd. (LFWD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years38.06%
3 Years58.72%
TTM-14.14%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM31.19%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM53.47%
Return on Capital
10 Years-89.19%
5 Years-49.64%
3 Years-67.4%
Last Year-108.54%
LFWD Recent Earnings
Lifeward Ltd. (LFWD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 4/12 qtrs (33%)
Q4 2025Latest
Nov 14, 2025EPS
$0.20
Est $0.09
-122.2%
Revenue
$6M
Est $8M
-21.3%
Q3 2025
Aug 14, 2025EPS
$0.58
Est $0.25
-132.0%
Revenue
$6M
Est $7M
-13.5%
Q2 2025
May 15, 2025EPS
$0.46
Est $0.33
-39.4%
Revenue
$5M
Est $7M
-23.9%
Q2 2025
Mar 7, 2025EPS
$0.38
Est $0.20
-90.0%
Revenue
$8M
Est $8M
+0.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 14, 2025 | $0.20vs $0.09-122.2% | $6Mvs $8M-21.3% |
| Q3 2025 | Aug 14, 2025 | $0.58vs $0.25-132.0% | $6Mvs $7M-13.5% |
| Q2 2025 | May 15, 2025 | $0.46vs $0.33-39.4% | $5Mvs $7M-23.9% |
| Q2 2025 | Mar 7, 2025 | $0.38vs $0.20-90.0% | $8Mvs $8M+0.2% |
Based on last 12 quarters of dataView full earnings history →
LFWD Peer Comparison
Lifeward Ltd. (LFWD) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EKSO | 28.63M | 11.80 | -2.40 | -28.6% | -135.66% | -177.4% | 0.29 | |
 IRBT | 1.72M | 0.05 | -0.01 | -23.44% | -38.16% | -112.92% | 3.71 | |
 MBOT | 147.08M | 2.19 | -3 | -37.06% | 0.03 | |||
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 | |
 ABT | 149.97B | 86.25 | 11.29 | 4.59% | 31.88% | 27.26% | 0.32 |
Compare LFWD vs Peers
Lifeward Ltd. (LFWD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFWD Income Statement
Lifeward Ltd. (LFWD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.75M | 6.54M | 4.87M | 4.39M | 5.97M | 5.51M | 13.85M | 25.66M | 22.03M |
| Revenue Growth % | 32.1% | -15.58% | -25.55% | -9.85% | 35.81% | -7.63% | 151.39% | 85.24% | -14.14% |
| Cost of Goods Sold | 4.65M | 3.72M | 2.15M | 2.2M | 3.06M | 3.61M | 9.4M | 17.45M | 13.61M |
| COGS % of Revenue | 60% | 56.84% | 44.06% | 50.17% | 51.34% | 65.43% | 67.86% | 67.98% | 61.75% |
| Gross Profit | 3.1M▲ 0% | 2.83M▼ 8.9% | 2.73M▼ 3.5% | 2.19M▼ 19.7% | 2.9M▲ 32.6% | 1.91M▼ 34.4% | 4.45M▲ 133.8% | 8.22M▲ 84.5% | 8.43M▲ 2.6% |
| Gross Margin % | 40% | 43.16% | 55.94% | 49.83% | 48.66% | 34.57% | 32.14% | 32.02% | 38.25% |
| Gross Profit Growth % | 321.33% | -8.9% | -3.5% | -19.7% | 32.62% | -34.38% | 133.75% | 84.5% | 2.58% |
| Operating Expenses | 25.09M | 22.04M | 16.77M | 14.19M | 15.56M | 21.01M | 28.07M | 27.77M | 25.32M |
| OpEx % of Revenue | 323.66% | 336.73% | 344.22% | 323.08% | 260.78% | 381.18% | 202.58% | 108.21% | 114.91% |
| Selling, General & Admin | 19.05M | 14.69M | 11.43M | 10.73M | 12.62M | 16.98M | 23.92M | 23.14M | 22.07M |
| SG&A % of Revenue | 245.72% | 224.45% | 234.48% | 244.34% | 211.52% | 308.04% | 172.64% | 90.18% | 100.16% |
| Research & Development | 6.04M | 7.35M | 5.35M | 3.46M | 2.94M | 4.03M | 4.15M | 4.63M | 3.25M |
| R&D % of Revenue | 77.93% | 112.28% | 109.75% | 78.74% | 49.26% | 73.14% | 29.94% | 18.02% | 14.75% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.99M▲ 0% | -19.21M▲ 12.6% | -14.05M▲ 26.9% | -12M▲ 14.6% | -12.65M▼ 5.4% | -19.1M▼ 50.9% | -23.61M▼ 23.6% | -19.55M▲ 17.2% | -16.89M▲ 13.6% |
| Operating Margin % | -283.66% | -293.57% | -288.28% | -273.25% | -212.12% | -346.62% | -170.43% | -76.19% | -76.66% |
| Operating Income Growth % | 27.76% | 12.63% | 26.89% | 14.55% | -5.42% | -50.94% | -23.61% | 17.19% | 13.61% |
| EBITDA | -21.35M | -18.75M | -13.73M | -11.72M | -12.39M | -18.9M | -21.77M | -15.71M | -16.56M |
| EBITDA Margin % | -275.38% | -286.49% | -281.7% | -266.77% | -207.66% | -342.95% | -157.1% | -61.22% | -75.15% |
| EBITDA Growth % | 28.22% | 12.17% | 26.79% | 14.63% | -5.72% | -52.55% | -15.16% | 27.81% | -5.38% |
| D&A (Non-Cash Add-back) | 642K | 463K | 321K | 285K | 266K | 202K | 1.85M | 3.84M | 333K |
| EBIT | -22.15M | -19.28M | -14.04M | -12.02M | -12.62M | -19.08M | -23.61M | -28.77M | -16.89M |
| Net Interest Income | -2.48M | -2.42M | -1.53M | -930K | -25K | -22K | 1.33M | 515K | -295K |
| Interest Income | 0 | 0 | 0 | - | 0 | 0 | 1.35M | 643K | 0 |
| Interest Expense | 2.48M | 2.42M | 1.53M | 930K | 25K | 22K | 20K | 128K | 295K |
| Other Income/Expense | -2.61M | -2.47M | -1.5M | -921K | 13K | 0 | 1.47M | -9.35M | -3.08M |
| Pretax Income | -24.6M▲ 0% | -21.68M▲ 11.9% | -15.54M▲ 28.3% | -12.93M▲ 16.8% | -12.64M▲ 2.2% | -19.1M▼ 51.1% | -22.14M▼ 15.9% | -28.9M▼ 30.5% | -19.97M▲ 30.9% |
| Pretax Margin % | -317.27% | -331.25% | -318.98% | -294.22% | -211.9% | -346.62% | -159.85% | -112.61% | -90.63% |
| Income Tax | 119K | -5K | 7K | 51K | 94K | 467K | -12K | 43K | -55K |
| Effective Tax Rate % | -0.48% | 0.02% | -0.05% | -0.39% | -0.74% | -2.44% | 0.05% | -0.15% | 0.28% |
| Net Income | -24.72M▲ 0% | -21.68M▲ 12.3% | -15.55M▲ 28.3% | -12.98M▲ 16.6% | -12.74M▲ 1.8% | -19.57M▼ 53.7% | -22.13M▼ 13.1% | -28.94M▼ 30.8% | -19.91M▲ 31.2% |
| Net Margin % | -318.81% | -331.17% | -319.13% | -295.38% | -213.48% | -355.09% | -159.76% | -112.78% | -90.38% |
| Net Income Growth % | 23.95% | 12.31% | 28.25% | 16.56% | 1.85% | -53.65% | -13.1% | -30.76% | 31.19% |
| Net Income (Continuing) | -24.72M | -21.68M | -15.55M | -12.98M | -12.74M | -19.57M | -22.13M | -28.94M | -19.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2567.76▲ 0% | -1236.48▲ 51.8% | -226.80▲ 81.7% | -68.88▲ 69.6% | -22.32▲ 67.6% | -26.40▼ 18.3% | -31.08▼ 17.7% | -39.96▼ 28.6% | -17.16▲ 57.1% |
| EPS Growth % | 50.43% | 51.85% | 81.66% | 69.63% | 67.6% | -18.28% | -17.73% | -28.57% | 57.06% |
| EPS (Basic) | -2567.76 | -1236.48 | -226.80 | -68.88 | -22.32 | -26.40 | -31.08 | -39.96 | -17.16 |
| Diluted Shares Outstanding | 9.62K | 17.52K | 68.58K | 187.6K | 570.43K | 742.31K | 710.66K | 723.98K | 11.61M |
| Basic Shares Outstanding | 9.62K | 17.52K | 68.58K | 187.6K | 570.43K | 742.31K | 710.66K | 723.98K | 11.61M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
LFWD Balance Sheet
Lifeward Ltd. (LFWD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 20.94M | 13.24M | 21.07M | 25.25M | 92.52M | 72.51M | 39.22M | 21.29M | 15.81M |
| Cash & Short-Term Investments | 14.57M | 9.55M | 16.25M | 20.35M | 88.34M | 67.9M | 28.08M | 6.94M | 2.17M |
| Cash Only | 14.57M | 9.55M | 16.25M | 20.35M | 88.34M | 67.9M | 28.08M | 6.94M | 2.17M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.1M | 758K | 794K | 684K | 585K | 1.04M | 3.12M | 6M | 6.14M |
| Days Sales Outstanding | 51.93 | 42.27 | 59.47 | 56.83 | 35.79 | 68.62 | 82.2 | 85.39 | 101.68 |
| Inventory | 4.28M | 2.61M | 3.37M | 3.54M | 2.99M | 2.93M | 5.65M | 6.72M | 5.73M |
| Days Inventory Outstanding | 335.58 | 256.19 | 572.75 | 586.58 | 356.18 | 296.47 | 219.48 | 140.65 | 153.77 |
| Other Current Assets | 649K | 167K | 339K | 120K | 270K | 233K | 1M | 578K | 1.77M |
| Total Non-Current Assets | 1.93M | 1.73M | 3.3M | 2.82M | 2.23M | 1.73M | 23.97M | 9.19M | 7.09M |
| Property, Plant & Equipment | 840K | 626K | 2.24M | 1.79M | 1.17M | 1.03M | 3.12M | 1.42M | 2.13M |
| Fixed Asset Turnover | 9.23x | 10.46x | 2.18x | 2.46x | 5.12x | 5.34x | 4.44x | 18.14x | 10.35x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 7.54M | 7.54M | 4.75M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 12.53M | 0 | 0 |
| Long-Term Investments | 856K | 801K | 739K | 704K | 713K | 659K | 709K | 362K | 410K |
| Other Non-Current Assets | 229K | 298K | 322K | 329K | 351K | 35K | 75K | -122K | -201K |
| Total Assets | 22.86M▲ 0% | 14.96M▼ 34.6% | 24.37M▲ 62.9% | 28.07M▲ 15.2% | 94.75M▲ 237.6% | 74.24M▼ 21.7% | 63.19M▼ 14.9% | 30.49M▼ 51.8% | 22.9M▼ 24.9% |
| Asset Turnover | 0.34x | 0.44x | 0.20x | 0.16x | 0.06x | 0.07x | 0.22x | 0.84x | 0.96x |
| Asset Growth % | -28.02% | -34.56% | 62.89% | 15.16% | 237.59% | -21.65% | -14.88% | -51.75% | -24.89% |
| Total Current Liabilities | 9.73M | 5.38M | 10.17M | 4.67M | 4.04M | 4.78M | 11.79M | 10.22M | 12.04M |
| Accounts Payable | 1.81M | 2.33M | 2.7M | 2.27M | 1.38M | 1.95M | 5.07M | 5.02M | 5.59M |
| Days Payables Outstanding | 142.09 | 228.42 | 458.67 | 375.6 | 164.92 | 197.38 | 196.81 | 105.06 | 149.96 |
| Short-Term Debt | 6.44M | 1.72M | 6.08M | 0 | 0 | 0 | 0 | 858K | 425K |
| Deferred Revenue (Current) | 123K | 237K | 323K | 441K | 316K | 301K | 1.5M | 1.25M | 0 |
| Other Current Liabilities | 480K | 445K | 402K | 432K | 555K | 685K | 1.89M | 1.76M | 6.02M |
| Current Ratio | 2.15x | 2.46x | 2.07x | 5.41x | 22.91x | 15.16x | 3.33x | 2.08x | 1.31x |
| Quick Ratio | 1.71x | 1.97x | 1.74x | 4.65x | 22.17x | 14.55x | 2.85x | 1.43x | 0.84x |
| Cash Conversion Cycle | 245.41 | 70.04 | 173.55 | 267.82 | 227.05 | 167.71 | 104.87 | 120.98 | 105.49 |
| Total Non-Current Liabilities | 9.43M | 7.63M | 3.42M | 1.63M | 1.33M | 1.29M | 4.89M | 1.41M | 2.45M |
| Long-Term Debt | 8.91M | 6.96M | 1.53M | 0 | 0 | 0 | 0 | 0 | 1.16M |
| Capital Lease Obligations | 0 | 0 | 1.31M | 923K | 418K | 333K | 607K | 22K | 1.16M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 256K | 239K | 61K | 35K | 45K | 66K | 2.77M | 67K | 61K |
| Total Liabilities | 19.16M | 13.02M | 13.59M | 6.29M | 5.37M | 6.07M | 16.68M | 11.64M | 14.49M |
| Total Debt | 15.35M | 8.69M | 8.92M | 1.58M | 1.06M | 897K | 1.9M | 880K | 1.58M |
| Net Debt | 785K | -859K | -7.34M | -18.77M | -87.28M | -67M | -26.18M | -6.06M | -585K |
| Debt / Equity | 4.14x | 4.47x | 0.83x | 0.07x | 0.01x | 0.01x | 0.04x | 0.05x | 0.19x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -8.86x | -7.93x | -9.18x | -12.91x | -506.20x | -868.27x | -1180.60x | -152.76x | -57.26x |
| Total Equity | 3.71M▲ 0% | 1.95M▼ 47.5% | 10.78M▲ 454.2% | 21.77M▲ 102.0% | 89.38M▲ 310.5% | 68.17M▼ 23.7% | 46.51M▼ 31.8% | 18.85M▼ 59.5% | 8.41M▼ 55.4% |
| Equity Growth % | -55.12% | -47.53% | 454.24% | 101.99% | 310.5% | -23.74% | -31.77% | -59.47% | -55.39% |
| Book Value per Share | 385.25 | 111.00 | 157.18 | 116.06 | 156.69 | 91.83 | 65.45 | 26.04 | 0.72 |
| Total Shareholders' Equity | 3.71M | 1.95M | 10.78M | 21.77M | 89.38M | 68.17M | 46.51M | 18.85M | 8.41M |
| Common Stock | 84K | 193K | 504K | 1.83M | 4.66M | 4.49M | 4.49M | 4.59M | 6.21M |
| Retained Earnings | -131.22M | -152.92M | -168.47M | -181.44M | -194.18M | -213.75M | -235.88M | -264.82M | -284.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -2.43M | -3.2M | -3.2M | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LFWD Cash Flow Statement
Lifeward Ltd. (LFWD) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -22.5M | -14.77M | -14.81M | -12.59M | -11.47M | -17.89M | -20.67M | -21.72M | -16.83M |
| Operating CF Margin % | -290.18% | -225.73% | -304.02% | -286.57% | -192.24% | -324.64% | -149.18% | -84.63% | -76.36% |
| Operating CF Growth % | 18.3% | 34.33% | -0.28% | 15.03% | 8.9% | -55.99% | -15.52% | -5.09% | 22.53% |
| Net Income | -24.72M | -21.68M | -15.55M | -12.98M | -12.74M | -19.57M | -22.13M | -28.94M | -16.23M |
| Depreciation & Amortization | 642K | 463K | 321K | 285K | 266K | 202K | 1.85M | 3.84M | 333K |
| Stock-Based Compensation | 0 | 0 | 1.11M | 749K | 833K | 993K | 1.33M | 1.28M | 743K |
| Deferred Taxes | 73K | -107K | -57K | -44K | -29K | 316K | -45K | 0 | 0 |
| Other Non-Cash Items | 7.42M | 2.3M | 0 | -392K | 0 | 79K | -326K | 7.08M | -1.37M |
| Working Capital Changes | -2.59M | 2.96M | -636K | -211K | 197K | 88K | -1.34M | -4.97M | -298K |
| Change in Receivables | 151K | 322K | -36K | 110K | 99K | -408K | -311K | -2.88M | -134K |
| Change in Inventory | -582K | 1.4M | -1.22M | -469K | 432K | -117K | -277K | -920K | 896K |
| Change in Payables | -1.61M | 492K | 370K | -506K | -884K | 566K | 1.04M | -47K | -347K |
| Cash from Investing | -21K | -13K | -22K | -73K | -47K | -25K | -18.15M | 0 | -16K |
| Capital Expenditures | -21K | -13K | -22K | -73K | -47K | -25K | -81K | 0 | -16K |
| CapEx % of Revenue | 0.27% | 0.2% | 0.45% | 1.66% | 0.79% | 0.45% | 0.58% | - | 0.07% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | -18.07M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 13.41M | 9.71M | 21.48M | 16.72M | 79.51M | -2.5M | -992K | 0 | 12.2M |
| Debt Issued (Net) | -3.1M | -3.87M | -1.72M | -6.57M | 0 | 0 | 0 | 0 | 1.44M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -992K | 0 | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -2.5M | -992K | 0 | 0 |
| Other Financing | 38K | 0 | 11.39M | 4.22M | 15.06M | 0 | 0 | 0 | 1.56M |
| Net Change in Cash | -9.11M▲ 0% | -5.02M▲ 44.9% | 6.64M▲ 232.3% | 4.06M▼ 38.9% | 68M▲ 1574.0% | -20.5M▼ 130.1% | -39.76M▼ 94.0% | -21.68M▲ 45.5% | -4.53M▲ 79.1% |
| Free Cash Flow | -22.52M▲ 0% | -14.79M▲ 34.3% | -14.84M▼ 0.3% | -12.66M▲ 14.7% | -11.52M▲ 9.1% | -17.92M▼ 55.6% | -20.75M▼ 15.8% | -21.72M▼ 4.7% | -16.83M▲ 22.5% |
| FCF Margin % | -290.46% | -225.93% | -304.47% | -288.23% | -193.03% | -325.1% | -149.76% | -84.63% | -76.36% |
| FCF Growth % | 19.54% | 34.34% | -0.34% | 14.66% | 9.05% | -55.57% | -15.81% | -4.68% | 22.53% |
| FCF per Share | -2340.31 | -843.87 | -216.33 | -67.49 | -20.19 | -24.14 | -29.20 | -30.00 | -1.45 |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.68x | 0.95x | 0.97x | 0.90x | 0.91x | 0.93x | 0.75x | 0.84x |
| Interest Paid | 2.3M | 1.5M | 1.5M | 862K | 0 | 0 | 1.34M | 0 | 0 |
| Taxes Paid | 21K | 25K | 21K | 13K | 40K | 113K | 126K | 0 | 0 |
LFWD Key Ratios
Lifeward Ltd. (LFWD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -393.5% | -413.09% | -766.99% | -244.42% | -79.72% | -22.92% | -24.84% | -38.6% | -88.56% | -146.12% |
| Return on Invested Capital (ROIC) | -879.8% | -465.47% | -516.69% | -465.17% | -279.12% | -371.33% | -875.97% | -164.77% | -88.57% | -122.94% |
| Gross Margin | 12.54% | 40% | 43.16% | 55.94% | 49.83% | 48.66% | 34.57% | 32.14% | 32.02% | 38.25% |
| Net Margin | -553.81% | -318.81% | -331.17% | -319.13% | -295.38% | -213.48% | -355.09% | -159.76% | -112.78% | -90.38% |
| Debt / Equity | 2.18x | 4.14x | 4.47x | 0.83x | 0.07x | 0.01x | 0.01x | 0.04x | 0.05x | 0.19x |
| Interest Coverage | -15.14x | -8.86x | -7.93x | -9.18x | -12.91x | -506.20x | -868.27x | -1180.60x | -152.76x | -57.26x |
| FCF Conversion | 0.85x | 0.91x | 0.68x | 0.95x | 0.97x | 0.90x | 0.91x | 0.93x | 0.75x | 0.84x |
| Revenue Growth | - | 32.1% | -15.58% | -25.55% | -9.85% | 35.81% | -7.63% | 151.39% | 85.24% | -14.14% |
LFWD Frequently Asked Questions
Lifeward Ltd. (LFWD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Lifeward Ltd. (LFWD) reported $22.0M in revenue for fiscal year 2025. This represents a 275% increase from $5.9M in 2016.
Lifeward Ltd. (LFWD) saw revenue decline by 14.1% over the past year.
Lifeward Ltd. (LFWD) reported a net loss of $19.9M for fiscal year 2025.
Dividend & Returns
Lifeward Ltd. (LFWD) has a return on equity (ROE) of -146.1%. Negative ROE indicates the company is unprofitable.
Lifeward Ltd. (LFWD) had negative free cash flow of $16.8M in fiscal year 2025, likely due to heavy capital investments.
Explore More LFWD
Lifeward Ltd. (LFWD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates